Steven W. Lefkowitz - 14 Jan 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Steven W Lefkowitz
Issuer symbol
CRMD
Transactions as of
14 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 18:02:56 UTC
Previous filing
23 Feb 2022
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 60,498 14 Jan 2023 Direct
holding CRMD Common Stock 30,152 14 Jan 2023 Direct F1
holding CRMD Common Stock 2,000 14 Jan 2023 Reporting Person's Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20,000 $0.000000 20,000 14 Jan 2023 Common Stock 20,000 $4.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
F2 These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.